MetaCap

Abeona Therapeutics (ABEO) vs Nature's Sunshine Products (NATR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Abeona Therapeutics (ABEO) has outperformed Nature's Sunshine Products (NATR) over the past year, losing 46.0% versus a loss of 51.8%. Over five years, NATR leads with a -40.4% price change compared with -86.7% for ABEO. Nature's Sunshine Products is the larger company by market cap ($176.4 million vs $165.3 million), about 1.1 times the size.

Abeona Therapeutics converts more of its revenue into profit, with a net margin of 1223.1% versus 4.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ABEO-45.98%NATR-51.84%
+72%+7%-58%
Nov 21, 20251 yearNov 20, 2026
ABEO-86.92%NATR-44.52%
+58%-18%-95%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ABEO versus NATR key metrics
MetricABEONATR
Share price$2.42$10.18
Market cap$165.31M$176.41M
1-day change-1.22%+0.10%
YTD return-54.08%-52.83%
1-year return-45.98%-51.84%
5-year return-86.74%-40.40%
P/E ratio (TTM)—12.41
Forward P/E—10.77
EPS (TTM)$-1.16$0.82
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$5.82M$480.14M
Revenue growth (YoY)—+5.67%
Net income (latest FY)$71.18M$19.52M
Gross margin73.68%72.42%
Operating margin-1536.91%5.15%
Net margin1223.08%4.07%
52-week high$7.65$28.14
52-week low$2.09$9.38
Distance from 52-week high-68.37%-63.82%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+542.98%+62.08%
Average volume1.66M168.24K
Shares outstanding68.31M17.33M
Employees226806
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Abeona Therapeutics is more profitable, keeping 1223.1 cents of every revenue dollar as net income versus 4.1 cents for Nature's Sunshine Products.

About Abeona Therapeutics

ABEO stock →

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa.

Health Care · Biotechnology: Pharmaceutical Preparations · 226 employees

About Nature's Sunshine Products

NATR stock →

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.

Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees

ABEO vs NATR FAQ

Which is bigger, Abeona Therapeutics or Nature's Sunshine Products?

Nature's Sunshine Products (NATR) is larger, with a market capitalization of $176.41M compared with $165.31M for Abeona Therapeutics (ABEO).

Which stock has performed better over the past year, ABEO or NATR?

ABEO returned -45.98% over the past 12 months, compared with -51.84% for NATR (price return, excluding dividends). Past performance does not predict future results.

Are Abeona Therapeutics and Nature's Sunshine Products in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons